As usual, the title is misleading.<p>The main idea is that a company called Kernel is putting forth $100m to start researching intrusive BCI technology (as opposed to nonintrusive BCI technology such as EEG/fNIRS/etc.).<p>This seems awfully strange considering scientists don't really know much about thoughts and disorders -- let alone how we would use direct neurotransmitter application to combat or enhance these things.<p>$100m sounds like quite a lot for something so speculative. Seems like what we'll end up with this endeavor is something like a new bipolar/schizophrenia pill, not nano-bots and networked brain-to-brain communication (which is what they want you to believe). Maybe that stuff is still 50 years away.<p>I sure hope I'm wrong. If anyone knows more about this company, please share links.